3 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Insider buying
3 insiders in a week, 8th time since 2021Traded Jul 29 · filed 2 days later
Since the trade −71.0% · S&P 500 −5.4% · to Nov 20
Bought 93% below the 52-week high, RSI 27, 69% under its 200-day average
The CEO of Hcw Biologics paid $60K out of pocket for Hcw Biologics shares. 2 other people at Hcw Biologics bought some too, in the same month. Shares held went up 23% with this purchase.
Insider buying
3 insiders in a week, 8th time since 2021Traded Jul 29 · filed 2 days later
Since the trade −71.0% · S&P 500 −5.4% · to Nov 20
Bought 93% below the 52-week high, RSI 27, 69% under its 200-day average
Insider buying
3 insiders in a week, 8th time since 2021Traded Jul 29 · filed 2 days later
Since the trade −71.0% · S&P 500 −5.4% · to Nov 20
Bought 93% below the 52-week high, RSI 27, 69% under its 200-day average
Insider buying
3 insiders in a week, 7th time since 2021Traded May 22 · filed 5 days later
Since the trade −95.7% · S&P 500 −7.5% · to Nov 20
Bought 65% below the 52-week high, RSI 87, 37% above its 200-day average, 382 points ahead of the S&P 500 over 3 months
Insider buying
3 insiders in a week, 7th time since 2021Traded May 22 · filed 5 days later
Since the trade −95.7% · S&P 500 −7.5% · to Nov 20
Bought 65% below the 52-week high, RSI 87, 37% above its 200-day average, 382 points ahead of the S&P 500 over 3 months
Insider buying
3 insiders in a week, 7th time since 2021Traded May 22 · filed 5 days later
Since the trade −95.7% · S&P 500 −7.5% · to Nov 20
Bought 65% below the 52-week high, RSI 87, 37% above its 200-day average, 382 points ahead of the S&P 500 over 3 months
Insider buying
Traded May 16, 2025 · filed 4 days later
Since the trade −98.6% · S&P 500 +16.1% · to Nov 20
A Hcw Biologics director paid $100K out of pocket for Hcw Biologics shares. 5 other people at Hcw Biologics bought some too, in the same month. Shares held went up 111% with this purchase.
Insider buying
Traded May 16, 2025 · filed 4 days later
Since the trade −98.6% · S&P 500 +16.1% · to Nov 20
The CEO of Hcw Biologics paid $60K out of pocket for Hcw Biologics shares. 5 other people at Hcw Biologics bought some too, in the same month.
Insider buying
Traded May 16, 2025 · filed 4 days later
Since the trade −98.6% · S&P 500 +16.1% · to Nov 20
A Hcw Biologics director paid $10K out of pocket for Hcw Biologics shares. 5 other people at Hcw Biologics bought some too, in the same month. Shares held went up 49% with this purchase.
Insider buying
Traded May 8, 2025 · filed 1 day later
Since the trade −98.3% · S&P 500 +22.1% · to Nov 20
The CEO of Hcw Biologics paid $2.4M out of pocket for Hcw Biologics shares. 5 other people at Hcw Biologics bought some too, in the same month. Shares held went up 23% with this purchase.
Insider buying
Traded May 8, 2025 · filed 1 day later
Since the trade −98.3% · S&P 500 +22.1% · to Nov 20
The CFO of Hcw Biologics paid $220K out of pocket for Hcw Biologics shares. 5 other people at Hcw Biologics bought some too, in the same month. Shares held went up 25% with this purchase.
Insider buying
Traded May 8, 2025 · filed 1 day later
Since the trade −98.3% · S&P 500 +22.1% · to Nov 20
A Hcw Biologics director paid $140K out of pocket for Hcw Biologics shares. 5 other people at Hcw Biologics bought some too, in the same month. Shares held went up 80% with this purchase.
Insider buying
Traded May 8, 2025 · filed 1 day later
Since the trade −98.3% · S&P 500 +22.1% · to Nov 20
A Hcw Biologics director paid $60K out of pocket for Hcw Biologics shares. 5 other people at Hcw Biologics bought some too, in the same month. Shares held went up 543% with this purchase.
Insider buying
Traded May 8, 2025 · filed 1 day later
Since the trade −98.3% · S&P 500 +22.1% · to Nov 20
A Hcw Biologics director paid $25K out of pocket for Hcw Biologics shares. 5 other people at Hcw Biologics bought some too, in the same month. Shares held went up 87% with this purchase.
Insider buying
Traded May 8, 2025 · filed 1 day later
Since the trade −98.3% · S&P 500 +22.1% · to Nov 20
Hcw Biologics's SVP of Business Development paid $25K out of pocket for Hcw Biologics shares. 5 other people at Hcw Biologics bought some too, in the same month. Shares held went up 20% with this purchase.